جست‌وجوی استاد و پژوهشگر

• Healthy Ageing
• Disability-Free Life Expectancy
• Socioeconomic Inequalities in Health
• +۵ مورد دیگر

Dr Andrew Kingston is a Research Fellow at Newcastle University specializing in gerontology and health inequalities research. His work primarily focuses on healthy ageing, disability-free life expectancy, and socioeconomic determinants of health in older populations, with extensive contributions to the Newcastle 85+ Study cohort. His research interests center on healthy ageing trajectories , socioeconomic inequalities in disability , and polypharmacy in the very old . Kingston employs advanced epidemiological methods including longitudinal cohort analysis, life table modelling, and qualitative approaches to examine how social determinants shape ageing outcomes. His work frequently addresses policy-relevant questions about social care needs, frailty measurement, and health equity in ageing populations. Analysis of his recent publications reveals strong thematic consistency in studying disability-free life expectancy across socioeconomic strata, with increasing focus on polypharmacy-social care interactions and class-based ageing experiences . His methodological approach combines quantitative modelling with qualitative insights, particularly evident in his work on ageing in place and assistive technology adoption. Kingston collaborates extensively with leading gerontology researchers including Professor Dame Louise Robinson, Emerita Professor Carol Jagger, and Professor Barbara Hanratty. His work frequently involves the English Longitudinal Study of Ageing (ELSA) and the Newcastle 85+ Study, contributing to major policy discussions about care needs forecasting and health inequality reduction strategies. He contributes to multidisciplinary research teams investigating socioeconomic patterning in ageing outcomes, with particular emphasis on translating epidemiological findings into actionable policy recommendations for reducing health inequalities in later life.

Chim Langمشاهده پروفایل

استاد بالینی

• Cardiology
• Clinical Pharmacology
• Cardio-metabolic Diseases
• +۹ مورد دیگر

Professor Chim Lang is a Clinical Professor of Cardiology in the School of Medicine at the University of Dundee, affiliated with Ninewells Hospital and Medical School, UK. He is a consultant cardiologist and clinical pharmacologist with extensive international training, including fellowships at Vanderbilt and Columbia Universities. He holds fellowships from the Royal Society of Edinburgh, Royal Colleges of Physicians, American College of Cardiology, and European Society of Cardiology. University: University of Dundee School: School of Medicine Department: Cardiovascular Research Academic Rank: Clinical Professor Email: C.C.Lang@dundee.ac.uk Professor Lang earned his BSc, MBBS, and MD from the University of Dundee, focusing on neurohormones and sodium homeostasis. His research expertise lies in cardio-metabolic diseases, with a multidisciplinary approach integrating pathophysiology, pharmacogenetics, and translational medicine. He leads a cardiovascular research laboratory focused on cardiac and vasomotor regulation, biomarker development, and novel therapeutic strategies. His recent publications highlight cutting-edge work in AI-based prediction of heart failure from retinal images, genetic risk profiling in aortic stenosis, neutrophil extracellular traps in HFpEF, and clinical trials such as REACH-HFpEF and CARDIATEAM. These studies reflect a strong trend toward precision medicine, digital health, and population-level informatics in cardiovascular care. Fellow of the Royal Society of Edinburgh (FRSE) Fellow of Royal Colleges of Physicians (London and Edinburgh) Fellow of American College of Cardiology Fellow of European Society of Cardiology British Pharmacological Society BrAPP Prize and Medal (1993) Fulbright Scholarship (2001) American Society for Clinical Pharmacology and Therapeutics Presidential Trainee Award (1995) Professor Lang has supervised 25 MD/PhD students and serves as an external examiner across multiple UK and Southeast Asian universities. He is Chief Investigator for major trials including MET-REMODEL, RECEDE, REFORM, and REACH-HFpEF, and leads the MRC UK-Malaysia PRIME project. His work has directly influenced clinical guidelines and FDA decisions, with two 4-star REF 2014 impact cases and recognition in REF 2021. He is also the UK National Coordinator for international trials such as COMMANDER-HF, ARISE, and SELECT. He leads or contributes to active research projects in multimorbidity in aging cancer patients, diabetes phenotyping (iDiabetes), and diabetic cardiomyopathy (CARDIATEAM), often in collaboration with international consortia and funded by BHF, MRC, NIHR, and EU programs.

Amy Pageمشاهده پروفایل

مدرس ارشد

• Deprescribing
• Quality Use of Medicines
• Geriatrics
• +۳ مورد دیگر

Dr. Amy Page is a Senior Lecturer in Pharmacy at the University of Western Australia's School of Allied Health and the inaugural Director of the Centre for Optimisation of Medicines. Her research focuses on deprescribing, quality use of medicines in geriatrics, and reducing polypharmacy-related harm in older adults. She has received over $13M in funding, published 160+ articles, and led influential projects like the Opti-med trial and development of the MATCH-D framework. Education & Qualifications: PhD (2017) MClinPharm (Clinical Pharmacy) GradDipBiostat (Biostatistics) GradCertDMEd (Diabetes Management Education) GradCertHProfEd (Health Professional Education) Research Interests: Dr. Page's work addresses medication optimization for older adults, with a focus on deprescribing strategies, polypharmacy reduction, and improving medication safety in aged care settings. She also develops clinical guidelines and educational programs for pharmacists. Key Achievements: Recipient of Australian Pharmacist of the Year (2024) and Young Pharmacist of the Year (2015) 2022 Vice-Chancellor’s Early Career Research Award Lead developer of national standards for pharmacist prescribing and aged care medication management Course Director for Doctor of Pharmacy Practice and Advanced Clinical Practice programs Grants & Impact: Over $13M in funding secured, leading projects such as the Centre of Research Excellence in Medicines and Ageing (CREMA) and the Safe Recovery initiative reducing hospital falls. Her work has influenced national policies like the APC accreditation standards and international frameworks like the Global Competency Framework. Teaching & Leadership: Oversees pharmacy postgraduate programs and pioneered microcredentials in clinical skills, prescribing, and diabetes education. Served as State President of the Pharmaceutical Society of Australia and on the Pharmacy Board of Australia.

• Social Cognition
• Prospective Memory
• Cognitive Aging
• +۳ مورد دیگر

Julie Henry is a Professor in the School of Psychology at The University of Queensland, with affiliate appointments at the Queensland Brain Institute and Mater Research Institute. As a Fellow of both the Academy of the Social Sciences in Australia and the Association for Psychological Science, she leads research on social cognition and prospection disruptions in aging and clinical populations. Her work examines how perception of social cues impacts mental health and relationships. Her research program investigates neural and behavioral aspects of social cognitive aging, prospective memory, and emotion regulation across clinical and non-clinical populations. Key interests include: Mechanisms of social cue processing in neurodegenerative conditions Age-related changes in affective forecasting and empathy Neurocognitive underpinnings of prospective memory Frailty and social wellbeing in late adulthood Recent publications demonstrate methodological diversity including meta-analyses, neuroimaging studies, virtual reality applications, and large-scale cohort analyses. Predominant themes include age-comparative designs, clinical translation of social cognition research, and technology-enhanced assessment tools. Her work consistently bridges cognitive neuroscience with real-world functioning. Honors include: UQ's Excellence in Graduate Research Training - Supervision Award (2023) Research Mentorship Award (2022) Research Higher Degree Supervision Award (2016) Lifetime Achiever recognition among Australia's top researchers (The Australian, 2021-2022) Consistent ranking in Stanford's top 2% global scientists She maintains continuous competitive funding including ARC Laureate (2025-2031), Discovery, and Linkage projects, plus NHMRC grants. As Director of The Queensland MIND Project, she leads multidisciplinary neurocognitive research. Her supervision has received institutional recognition, though specific student names aren't listed in source materials.

• Digital Health
• Cardiovascular Epidemiology
• Clinical Trials
• +۹ مورد دیگر

Professor Richard Hobbs is the Mercian Professor of Primary Care at the University of Oxford and serves as Pro-Vice-Chancellor (without portfolio) . He is affiliated with Jesus College and Harris Manchester College , directing the Oxford Institute of Digital Health and the NIHR Applied Research Collaboration . His academic career spans decades, focusing on digital health , cardiovascular epidemiology , and clinical trials , particularly in heart failure , stroke prevention , and disease prevention . With over 700 peer-reviewed publications and an h-index of 121 , his work has significantly influenced international health policies and clinical guidelines . He led the development of major trials such as BAFTA , SAFE , SMART , and TASMINH , which transformed hypertension and atrial fibrillation management. His research groups include Chronic Kidney Disease , Heart Failure , and Stroke Prevention . He received the RCGP Discovery Prize (2018) and was awarded a CBE for contributions to medical research. Supervising 4 DPhil students, he spearheads initiatives like the PANORAMIC trial (funded £18.5m) and advocates for academic primary care capacity globally.

Nadine H. Abdallahمشاهده پروفایل

استادیار

• Geriatric Oncology
• Multiple Myeloma
• Hematology
• +۵ مورد دیگر

Nadine H. Abdallah, M.D., serves as an Assistant Professor of Medicine and Oncology at Mayo Clinic College of Medicine and Science, holding a primary appointment as Senior Associate Consultant in the Division of Hematology within the Department of Internal Medicine at Mayo Clinic in Rochester, Minnesota. Her clinical and research focus centers on improving care for older patients with multiple myeloma and related plasma cell disorders. Dr. Abdallah's research program investigates the critical intersection of geriatric assessment and hematologic malignancies, with particular emphasis on how frailty, body composition, and social determinants of health impact treatment outcomes in elderly patients with multiple myeloma. Her work aims to personalize treatment strategies through comprehensive geriatric assessments while evaluating methods to reduce treatment-related toxicity and enhance quality of life for older cancer patients. Key focus areas include comprehensive geriatric assessment implementation in hematology practice using digital health technologies, body composition analysis in multiple myeloma, and risk stratification incorporating cytogenetic abnormalities. Analysis of Dr. Abdallah's recent publication record reveals a strong emphasis on geriatric oncology within hematology, particularly focusing on frailty assessment, treatment personalization for elderly patients, and the impact of body composition on outcomes in multiple myeloma. Her work bridges clinical hematology with geriatric medicine, creating novel approaches to risk assessment that incorporate both biological and functional parameters. Kern Health Care Delivery Scholar, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic (2023-2026) Outstanding Hematology and Oncology Fellow, Mayo Clinic in Rochester (2023) Student Award of the Naji Sahyoun Endowed Memorial Fund, American University of Beirut (2015) Dr. Abdallah maintains active professional engagement with multiple organizations including the Cancer and Aging Research Group, International Society of Geriatric Oncology (SIOG), European Society for Medical Oncology, American Society of Hematology, and American Society of Clinical Oncology. Her research program continues to advance the integration of geriatric principles into standard hematology practice, with particular focus on improving care delivery for older adults with plasma cell disorders.

• Trauma Surgery
• Surgical Critical Care
• Emergency General Surgery
• +۱ مورد دیگر

Dr. Toby M. Enniss is an Associate Professor of Surgery at the University of Utah, where he serves as the Trauma Medical Director of the University of Utah Level 1 Trauma Center and Director of the Acute Care Surgery Service. He joined the Department of Surgery in 2010 and has been instrumental in developing the Acute Care Surgery system at the university across clinical, educational, administrative, and research domains. His educational background includes: B.A. in Mathematics (with minors in Chemistry and Biology) from the University of Utah M.D. from the University of Utah School of Medicine MBA from the University of Utah General Surgery Residency at Wake Forest University-Baptist Medical Center Surgical Critical Care Fellowship at Wake Forest University-Baptist Medical Center Acute Care Surgery Fellowship at Wake Forest University-Baptist Medical Center Dr. Enniss' clinical and research expertise centers on Trauma Surgery, Surgical Critical Care, Emergency General Surgery, and Acute Care Surgery. His work focuses on improving trauma systems, including trauma triage, tourniquet use, management of traumatic brain injury in geriatric patients, and the development of clinical guidelines through national organizations. His research bridges clinical practice with system-level improvements in acute care delivery. Analysis of his recent publications reveals a dominant focus on multi-institutional trauma research, particularly in trauma triage protocols, extremity trauma management, geriatric trauma assessment, and hepatobiliary emergencies. Key contributions include validation of the Trauma-Specific Frailty Index and refinement of acute cholecystitis grading systems through AAST collaborations, demonstrating his leadership in evidence-based guideline development. Professional recognition includes: Fellow of the American College of Surgeons (FACS) Dr. Enniss actively shapes national trauma standards through committee service in the American Association for the Surgery of Trauma (AAST) and Eastern Association for the Surgery of Trauma (EAST), where he leads clinical guideline development and multi-institutional research initiatives. His administrative leadership as Trauma Medical Director encompasses oversight of research protocols, educational curriculum development for trainees, and implementation of quality improvement programs within the Level 1 Trauma Center. He directs the University of Utah's Acute Care Surgery Service, integrating trauma, emergency surgery, and critical care teams into a cohesive system that handles over 3,000 annual trauma activations. His operational leadership has established protocols for prehospital care coordination, geriatric trauma management, and interfacility transfers that serve as regional benchmarks.

• Geriatric Pharmacology
• Polypharmacy
• Frailty Assessment
• +۵ مورد دیگر

Sarah Hilmer is a Conjoint Professor of Geriatric Pharmacology at the Northern Clinical School of the University of Sydney . She is a member of the Charles Perkins Centre and specializes in research areas including Healthy Ageing and Lifespan . Her clinical focus is Gerontology , and she actively investigates polypharmacy , frailty , and the Drug Burden Index in older adults. Key Themes : Healthy Ageing, Lifespan Keywords : Ageing, Pharmacology, Gerontology Her research spans translational studies using mouse models to evaluate polypharmacy effects, clinical trials on deprescribing interventions, and health systems research to improve medication management in residential and hospital settings. Recent projects include developing computerised clinical decision support tools and digital patient support hubs for frail older adults. Her 15 most recent articles (2023–2025) focus on deprescribing in dementia care, polypharmacy impacts on physical function, and implementation science for medication safety. Trends highlight interdisciplinary approaches to frailty assessment , drug interaction management , and health equity in aged care. She mentors PhD students like Esther Afolabi and Edward Lau , who are working on digital health tools and clinical decision support for frailty. Her work intersects with geriatric comanagement in surgical patients and antimicrobial stewardship in residential aged care.

Ahmad Nassrمشاهده پروفایل

استاد

• Spinal Surgery
• Cervical Spine Pathology
• Motion Preservation Surgery
• +۷ مورد دیگر

Ahmad Nassr, M.D., is a Professor of Orthopedic Surgery and Neurosurgery at Mayo Clinic School of Medicine, with primary appointments as a Consultant in the Department of Orthopedic Surgery. He holds joint appointments in Physiology & Biomedical Engineering and Pediatric and Adolescent Medicine. His clinical expertise focuses on spinal disorders, including cervical spine pathology, motion preservation surgery, and osteoporosis treatment in the spine. Dr. Nassr completed his Mechanical Engineering degree at MIT, followed by medical training at the University of Pennsylvania, residency at Rush University, and spinal surgery fellowship at the University of Pittsburgh. His research emphasizes improving spinal surgery outcomes through innovations in bone quality assessment, fusion techniques, and minimizing complications. Notable contributions include studies on riluzole efficacy in spinal cord injury, teriparatide effects on lumbar fusion, and genomic screening for adjacent level degeneration. He has authored over 150 peer-reviewed publications and holds leadership roles in organizations like the Cervical Spine Research Society and Lumbar Spine Research Society. Dr. Nassr has received numerous awards, including the 2025 Coventry Award for Best Paper, 2022 Charles Kuntz Scholar Award, and multiple best research paper accolades from spinal societies. He leads the Spine Surgery Research program at Mayo Clinic and mentors trainees nationally. His clinical practice spans complex spinal surgeries, robotic spine procedures, and minimally invasive techniques. Dr. Nassr also serves as an FDA Orthopedic Device Panel member and chairs committees for spine trauma and surgical education.

Adam Daveyمشاهده پروفایل

استاد

• Gerontology
• Epidemiology of Aging
• Biostatistics
• +۴ مورد دیگر

Adam Davey is a Professor in the Department of Health Behavior & Nutrition Sciences at the University of Delaware’s College of Health Sciences. He holds a Ph.D. in Human Development and Family Studies from Penn State University, an M.Sc. in Family Studies from the University of Guelph, and a B.Sc. in Psychology and Spanish from the University of Toronto. His research focuses on gerontology, epidemiology of aging, biostatistics, and health disparities, particularly in conditions like chronic kidney disease and diabetes mellitus. He teaches courses such as HBNS 856: Multivariable Biostatistics and HBNS 634: Health Science Data Analysis. Research interests include studying aging populations, frailty markers, and the intersection of chronic diseases with sociocultural factors. His work often involves epidemiological analyses and statistical methodologies to address health equity gaps. Recent studies explore dietary patterns in children and adolescents, caregiving dynamics, and sleep quality’s impact on older adults’ health. Collaborations span public health interventions, nutritional epidemiology, and clinical gerontology. His publications (2021–2025) highlight trends in aging populations’ health challenges, including frailty, diabetes management, and disparities in healthcare access. He has contributed to studies on snack consumption in youth, centenarian health, and validation of clinical assessment tools like the Environmental Audit Scoring Evaluation (EASE) for long-term care settings. Dr. Davey’s academic contributions include methodological advancements in handling missing data in longitudinal studies and developing tools for evaluating healthcare environments. His work emphasizes translating research into actionable strategies for improving health outcomes across diverse populations.

Kwok-ming Hoمشاهده پروفایل

استاد مدعو

• Critical Care Medicine
• Neurology
• Trauma Surgery
• +۳ مورد دیگر

Kwok-ming Ho is an Adjunct Professor at the University of Western Australia (UWA) in the Department of Internal Medicine, affiliated with the UWA Medical School. He also holds an external position at The Chinese University of Hong Kong from July 2024 to June 2029. His research focuses on critical care medicine, neurology, and trauma surgery, with expertise in intensive care unit (ICU) practices, traumatic brain injury, and evidence-based clinical interventions. Research interests include investigating thromboprophylaxis protocols in ICUs, optimizing arterial cannulation techniques via ultrasound guidance, and understanding the epidemiology of dural venous sinus thrombosis in trauma patients. He explores associations between body mass index, frailty, and critical illness outcomes, as well as long-term cardiac effects of pulmonary embolism therapies. Ho has contributed to over 214 peer-reviewed publications and supervised three research projects. Notable collaborations include multinational studies on ICU protocols and systematic reviews of critical care interventions. He has secured grants for initiatives like the 'Multifaceted Approach to Improving Outcomes for Severely Injured Patients' and neuroprostanes research in neurological injury. He is associated with datasets on road trauma prevention and neurotrauma research. His work aligns with UN Sustainable Development Goals addressing health and well-being (SDG 3).

Aprill Dawsonمشاهده پروفایل

استادیار

• Diabetes Research
• Health Disparities
• Geriatric Medicine
• +۴ مورد دیگر

Aprill Z. Dawson, PhD, MPH, is an Assistant Professor in the Department of Medicine (General Internal Medicine) at the Medical College of Wisconsin (MCW), affiliated with the Center for Advancing Population Science (CAPS). She holds a Master of Public Health from the University of Texas Health Science Center (Houston, TX) and a PhD in Health and Rehabilitation Sciences (Health Services Track) from the Medical University of South Carolina. Her research focuses on understanding how cognitive impairment and functional limitations influence clinical and behavioral outcomes in older minority populations with type 2 diabetes, with an emphasis on health disparities and social determinants of health. Key areas include the impact of discrimination on health outcomes, healthcare utilization trends among marginalized groups, and interventions to reduce hospital readmissions and improve diabetes management. Her work spans global health (e.g., studies in Sub-Saharan Africa and Panama), disparities in chronic disease outcomes, and the interplay between socioeconomic factors and medical conditions. Notable projects include examining racial/ethnic differences in frailty and depression, analyzing trends in healthcare expenditures, and evaluating financial incentives for improving glycemic control in underserved populations. Dr. Dawson’s articles often address systemic inequities in healthcare access and outcomes, leveraging large datasets and mixed-methods approaches. She has contributed to policy-oriented research on hospital readmission reduction programs and telehealth applications in indigenous communities. While no academic awards are explicitly listed in the provided text, her extensive publication record reflects sustained contributions to population health science. Her training programs focus on enhancing diversity and inclusion in clinical research, with a recent emphasis on mentorship strategies for junior faculty from underrepresented backgrounds.

• Cardiology
• Interventional Cardiology
• Geriatric Cardiology
• +۳ مورد دیگر

Dae Yong Park is a Clinical Fellow at Yale School of Medicine , affiliated with the Department of Internal Medicine . He holds a MD from Seoul National University, College of Medicine (2017) and an MSc from Northwestern University, Feinberg School of Medicine (2024). His research focuses on interventional cardiology and geriatric cardiovascular care , analyzing outcomes of percutaneous coronary interventions (PCI) in atrial fibrillation and myocardial infarction patients. Recent work explores sex-based differences in anticoagulation therapy, frailty assessments in acute MI, and LDL cholesterol trends in aging populations. Key trends in his 9 peer-reviewed publications include health equity , guideline representation for older adults, and seasonal patterns in cardiovascular admissions. Scientific awards include Institutional Research Day Awards (2022, 2023) and Medal of Exemplary Conduct (2017). Collaborating frequently with researchers like Michael Nanna and Jennifer Frampton , his work bridges clinical practice , outcomes research , and interdisciplinary team science at Yale.

• Cardiology
• Neuroimmunology
• Precision Medicine
• +۳ مورد دیگر

Golsa Babapour is a Postdoctoral Research Fellow at Yale School of Medicine’s Department of Internal Medicine. She holds an MD from Tabriz University of Medical Sciences (2021) and has over two years of clinical experience in emergency medicine. Her research focuses on cardiology, neuroimmunology, precision medicine, and cardiovascular health outcomes. Dr. Babapour’s work explores maternal immune influences on brain development, AI-driven insights into autoimmune diseases, and optimizing therapies for cardiovascular conditions. Education MD in Medicine, Tabriz University of Medical Sciences (2021) Research Interests Her research spans cardiology (e.g., beta-blocker efficacy, coronary interventions) and neuroimmunology (e.g., maternal immune factors in brain development). She also investigates the application of precision medicine, AI, and public health strategies to address cardiovascular disparities and frailty-related outcomes. Grants & Advising No grants or trainees listed. Collaborates widely on translational cardiology and immunology projects. Labs & Teams Not specified in current profile; assumed involvement in Yale’s cardiovascular and immunology research groups.

John Machمشاهده پروفایل

پژوهشگر ارشد

• Geriatric Pharmacology
• Polypharmacy
• Biological Aging
• +۳ مورد دیگر

John Mach is Research Fellow and Laboratory Manager at the University of Sydney's Kolling Institute, leading basic science research in geriatric pharmacology. His work investigates biological mechanisms of polypharmacy-induced frailty and develops biomarkers to guide medication optimization in older adults. Current projects focus on: 1) Identifying blood biomarkers for geriatric prescribing 2) Deciphering reversibility of polypharmacy harms and 3) Informing chronic opioid deprescribing through bedside-to-bench approaches. His laboratory utilizes mouse aging models, hyperspectral imaging, and computational video analysis. Recent publications (2020-2025) demonstrate innovations in quantifying polypharmacy effects through drug burden indices, microbiome interactions, and functional assessments. Research shows age-sex differences in medication responses and reversibility through deprescribing. Awarded the ASCEPT Certara New Investigator Award (2022) and Kolling Emerging Leader (2021), he supervises doctoral candidates and promotes sustainable research culture through NSLHD Scientific Staff Council.